Escalon Medical (OTCMKTS:ESMC) Releases Earnings Results

Escalon Medical (OTCMKTS:ESMC – Get Free Report) released its earnings results on Monday. The medical equipment provider reported $0.02 EPS for the quarter, Zacks reports. Escalon Medical had a return on equity of 65.44% and a net margin of 31.50%. The firm had revenue of $3.71 million for the quarter.

Escalon Medical Stock Performance

Escalon Medical stock remained flat at $0.19 during mid-day trading on Wednesday. The company’s stock had a trading volume of 45,000 shares, compared to its average volume of 3,059. The company has a current ratio of 2.94, a quick ratio of 2.21 and a debt-to-equity ratio of 0.03. The company has a 50 day simple moving average of $0.17 and a 200 day simple moving average of $0.19. Escalon Medical has a 12 month low of $0.14 and a 12 month high of $0.28. The company has a market capitalization of $1.40 million, a PE ratio of 0.73 and a beta of 0.65.

About Escalon Medical

(Get Free Report)

Escalon Medical Corporation develops, manufactures and markets medical devices for ophthalmology. Its products support eye-care professionals in diagnosing and treating eye conditions, with a focus on diagnostic imaging and surgical applications. The company’s offerings include ophthalmic ultrasound systems and related diagnostic instruments, as well as products used in eye surgery. Its Sonomed line is associated with ophthalmic ultrasound technology. Escalon has served eye-care markets in the United States and internationally.

See Also

Earnings History for Escalon Medical (OTCMKTS:ESMC)

Receive News & Ratings for Escalon Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Escalon Medical and related companies with MarketBeat.com's FREE daily email newsletter.